Medical Cannabis for NHS Patients UK: What's Available?

Medical Cannabis on the NHS: The Reality for UK Patients

Since November 2018, medical cannabis has been technically legal to prescribe on the NHS in the UK. Yet the reality for most patients is starkly different: NHS medical cannabis prescriptions remain extraordinarily rare, leaving the vast majority of eligible patients to self-fund through private clinics.

This guide explains why, which patients the NHS will and will not prescribe for, and what your options are if you believe you may benefit from medical cannabis.

When Did Medical Cannabis Become Legal in the UK?

On 1 November 2018, the UK government rescheduled cannabis-derived medicinal products from Schedule 1 to Schedule 2 of the Misuse of Drugs Regulations 2001, following two high-profile cases involving children with severe treatment-resistant epilepsy — Alfie Dingley and Billy Caldwell.

This change permitted specialist doctors on the GMC register to prescribe cannabis-derived medicinal products for patients with an exceptional clinical need where other treatments had failed or were unsuitable.

What the NHS Currently Prescribes

In practice, NHS prescriptions for medical cannabis are limited to a very small number of conditions and circumstances:

Children with Treatment-Resistant Epilepsy

The NHS has established pathways — primarily through the NHS England Highly Specialised Service for Severe Intractable Epilepsy — for prescribing cannabis-based medicines (specifically Epidiolex, a purified CBD product) to children with:

• Dravet syndrome
• Lennox-Gastaut syndrome
• Tuberous sclerosis complex

These are the most clearly evidence-supported NHS indications. Even here, strict eligibility criteria apply.

Nausea from Chemotherapy

Nabilone (a synthetic cannabinoid) has been available on NHS prescription for chemotherapy-induced nausea and vomiting (CINV) for many years. This is a licensed medicine — not "medical cannabis" in the broader sense — and is considered within standard NHS oncology protocols.

Multiple Sclerosis Spasticity

Sativex (nabiximols), an oromucosal spray containing THC and CBD, is licensed in the UK for the treatment of moderate to severe spasticity in multiple sclerosis where other treatments have not provided adequate relief. NHS prescribing of Sativex is patchy — some NHS trusts include it in formulary; others do not.

Why Are NHS Prescriptions So Rare?

Several structural barriers prevent widespread NHS access:

• NICE guidance: The National Institute for Health and Care Excellence (NICE) has not recommended cannabis-based products for most conditions due to insufficient evidence from large-scale randomised controlled trials.
• Clinical inertia: Many NHS specialists are unfamiliar with prescribing cannabis-based medicines and are reluctant to take on the clinical and regulatory responsibility.
• Cost: NHS trusts are subject to budget constraints and are unlikely to fund treatments without NICE approval for routine use.
• Evidence threshold: NHS prescribing requires a robust clinical evidence base that medical cannabis, as a relatively recently legalised medication, has not yet fully established across all conditions.

What Conditions Are Private Clinics Prescribing For?

In contrast to the NHS, private UK medical cannabis clinics regularly prescribe for a wide range of conditions where clinical evidence is growing, including:

• Chronic pain (neuropathic, musculoskeletal, fibromyalgia)
• Anxiety and PTSD
• Sleep disorders
• Inflammatory bowel disease
• Multiple sclerosis symptoms
• Cancer-related pain and nausea
• Tourette's syndrome

Read about condition-specific options via our full guide library or explore available treatments on LeafMe products.

Can You Get a Referral from Your GP?

Your NHS GP cannot prescribe medical cannabis directly — only specialists can. However, your GP can refer you to an NHS specialist who may consider a cannabis-based prescription in exceptional circumstances.

In practice, this route is extremely slow and rarely successful for conditions outside the narrow NHS-approved categories. Most patients pursue the private route directly. A private prescription from a registered specialist is legally valid without any GP involvement.

What to Do If the NHS Won't Prescribe

1. Consult a private UK medical cannabis clinic — the process is straightforward and can often be completed within days.
2. Ensure your GP is informed of your private prescription for safety and drug interaction monitoring.
3. Review cost reduction options — see our monthly cost breakdown guide.
4. Consider applying to patient access schemes if cost is a barrier.

Summary

• NHS medical cannabis prescriptions are available in theory but extremely rare in practice.
• NHS coverage is largely limited to paediatric epilepsy (Epidiolex), chemotherapy nausea (Nabilone), and some MS spasticity cases (Sativex).
• The vast majority of UK patients access treatment through private clinics.
• GP referral to NHS specialists is possible but rarely results in prescription outside narrow indications.
• Private clinics offer faster, broader access — compare options in our clinic directory.